Tonix Pharmaceuticals Holding Corp (TNXP)
0.19
-0.01
(-6.95%)
USD |
NASDAQ |
Nov 22, 16:00
0.1807
-0.01
(-4.89%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash from Investing (Quarterly): -0.009M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -0.009M |
June 30, 2024 | 0.00 |
March 31, 2024 | -0.108M |
December 31, 2023 | -0.431M |
September 30, 2023 | -0.821M |
June 30, 2023 | -24.02M |
March 31, 2023 | -3.799M |
December 31, 2022 | -4.671M |
September 30, 2022 | -8.82M |
June 30, 2022 | -14.44M |
March 31, 2022 | -20.22M |
December 31, 2021 | -25.62M |
September 30, 2021 | -7.751M |
June 30, 2021 | -1.429M |
March 31, 2021 | -0.505M |
December 31, 2020 | -4.534M |
September 30, 2020 | -4.016M |
June 30, 2020 | -0.014M |
March 31, 2020 | 0.00 |
December 31, 2019 | -0.005M |
September 30, 2019 | -0.002M |
June 30, 2019 | -0.003M |
March 31, 2019 | -0.007M |
December 31, 2018 | 0.001M |
September 30, 2018 | -0.003M |
Date | Value |
---|---|
June 30, 2018 | -0.002M |
March 31, 2018 | -0.002M |
December 31, 2017 | -0.003M |
September 30, 2017 | 0.00 |
June 30, 2017 | 2.478M |
March 31, 2017 | 4.694M |
December 31, 2016 | 3.856M |
September 30, 2016 | 5.241M |
June 30, 2016 | 2.734M |
March 31, 2016 | 4.718M |
December 31, 2015 | -1.925M |
September 30, 2015 | -22.09M |
June 30, 2015 | -0.153M |
March 31, 2015 | 0.00 |
December 31, 2014 | -0.125M |
September 30, 2014 | -0.16M |
June 30, 2014 | -0.105M |
March 31, 2014 | -0.002M |
December 31, 2013 | -0.007M |
September 30, 2013 | -0.008M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | -0.0003M |
September 30, 2012 | -0.0019M |
June 30, 2012 | -0.0338M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.62M
Minimum
Dec 2021
--
Maximum
Mar 2020
-6.060M
Average
-2.614M
Median
Cash from Investing (Quarterly) Benchmarks
Abbott Laboratories | -594.00M |
Emergent BioSolutions Inc | 112.00M |
Geovax Labs Inc | -0.0207M |
Amicus Therapeutics Inc | 34.27M |
Chimerix Inc | 28.32M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -18.80M |
Cash from Financing (Quarterly) | 42.90M |
Free Cash Flow | -69.19M |
Free Cash Flow Per Share (Quarterly) | -0.3028 |
Free Cash Flow to Equity (Quarterly) | -18.31M |
Free Cash Flow Yield | -2.06K% |